Back to comparisons

Comparison

Nicotinamide Riboside (NR) vs Pterostilbene

FieldNicotinamide Riboside (NR)Pterostilbene
Categoryneuroprotectiveneuroprotective
Dose range250–1000mg50–250mg
Half-life
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs250280

The comparison in plain English

Auto-generated from data

Nicotinamide Riboside (NR) and Pterostilbene are both in the neuroprotective category respectively. Nicotinamide Riboside (NR) NAD+ precursor — the most-studied form for direct NAD+ elevation in humans. Pterostilbene Methylated analog of resveratrol with much higher bioavailability.

Bottom line

Nicotinamide Riboside (NR) (evidence A, safety 5/5) has a weaker evidence base than Pterostilbene (evidence B, safety 5/5). Nicotinamide Riboside (NR) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Nicotinamide Riboside (NR) if

Nicotinamide Riboside (NR) is the better fit when your goal aligns with its mechanism (Precursor in the NAD+ salvage pathway via NRK1 and NRK2 enzymes that phosphorylate NR to NMN, which then converts to NAD+) and the dose range (250–1000mg) suits your protocol. Half-life is —h.

Choose Pterostilbene if

Pterostilbene is the better fit when your goal aligns with its mechanism (Pterostilbene is structurally similar to resveratrol but with two methyl groups attached, increasing lipophilicity and substantially improving blood-brain-barrier penetration (4x oral bioavailability and a longer half-life vs resveratrol)) and the dose range (50–250mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →